The mitochondrial DNA common deletion as a potential biomarker of cancer-associated fibroblasts from skin basal and squamous cell carcinomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The mitochondrial DNA common deletion as a potential biomarker of cancer-associated fibroblasts from skin basal and squamous cell carcinomas ; volume:14 ; number:1 ; day:4 ; month:1 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (4.1.2024), 1-14, 12.2024
- Urheber
-
Fontana, Gabriele A.
MacArthur, Michael R.
Rotankova, Nadezhda
Di Filippo, Michela
Beer, Hans-Dietmar
Gahlon, Hailey
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-50213-1
- URN
-
urn:nbn:de:101:1-2024031910562953808708
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fontana, Gabriele A.
- MacArthur, Michael R.
- Rotankova, Nadezhda
- Di Filippo, Michela
- Beer, Hans-Dietmar
- Gahlon, Hailey
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities